Under construction – not a live service

Skip to content

Frontlight Research

Institution

Aichi Medical University

Nagakute, JapanWebsite

Also known as: Aichi ika daigaku · 愛知医科大学

2running trials

Running trials

Recruiting
Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma
NCT07235007· Aichi Medical University· Source
Active, not recruiting
Precise Procedural and PCI Plan (P4)
NCT05253677· CoreAalst BV· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Liver and biliary tract cancer1 recruiting

Registry name variants (1)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Aichi Medical University
Aichi
2 trials
- NCT07235007Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma
  Contact: Tadahisa Inoue
- NCT05253677Precise Procedural and PCI Plan (P4)

Conditions

Diseases this institution publishes on or runs trials for.

Institution data: ROR 02h6cs343 (CC0-1.0)Updated 12 Nov 2026

Report an error

Under construction, not live – Aichi Medical University: trials and research groups – Frontlight Research